ZA934222B - Pharmaceutical soft capsules containing lysine clonixinate - Google Patents

Pharmaceutical soft capsules containing lysine clonixinate

Info

Publication number
ZA934222B
ZA934222B ZA934222A ZA934222A ZA934222B ZA 934222 B ZA934222 B ZA 934222B ZA 934222 A ZA934222 A ZA 934222A ZA 934222 A ZA934222 A ZA 934222A ZA 934222 B ZA934222 B ZA 934222B
Authority
ZA
South Africa
Prior art keywords
soft capsules
capsules containing
containing lysine
pharmaceutical soft
lysine clonixinate
Prior art date
Application number
ZA934222A
Inventor
Carlos A Vasquez
Original Assignee
Roemmers Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roemmers Sa filed Critical Roemmers Sa
Publication of ZA934222B publication Critical patent/ZA934222B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA934222A 1992-06-16 1993-06-15 Pharmaceutical soft capsules containing lysine clonixinate ZA934222B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4219702A DE4219702A1 (en) 1992-06-16 1992-06-16 Pharmaceutical soft capsules containing lysine clonixinate and a process for the production thereof

Publications (1)

Publication Number Publication Date
ZA934222B true ZA934222B (en) 1994-01-17

Family

ID=6461132

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA934222A ZA934222B (en) 1992-06-16 1993-06-15 Pharmaceutical soft capsules containing lysine clonixinate

Country Status (13)

Country Link
EP (1) EP0574822A1 (en)
JP (1) JPH0665078A (en)
KR (1) KR940000108A (en)
CN (1) CN1037934C (en)
AU (1) AU656078B2 (en)
CA (1) CA2098410A1 (en)
DE (1) DE4219702A1 (en)
FI (1) FI932768A (en)
IE (1) IE930446A1 (en)
IL (1) IL105870A (en)
MX (1) MX9303582A (en)
NO (1) NO932097L (en)
ZA (1) ZA934222B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19849848A1 (en) * 1998-10-29 2000-05-04 Lohmann Therapie Syst Lts Oral application, spontaneous disintegration with liquid and dosage form and process for its preparation
KR20030042935A (en) * 2001-11-26 2003-06-02 알앤피코리아 주식회사 Clonixin lysinate formulation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3337570A (en) * 1965-10-23 1967-08-22 Schering Corp Substituted nicotinic acids and method for the manufacture thereof
US4144332A (en) * 1976-01-05 1979-03-13 The Regents Of The University Of Michigan Process for alleviating proliferative skin diseases
DE4037554A1 (en) * 1990-11-26 1992-05-27 Roemmers Sa MEDICAMENT FOR TOPICAL APPLICATION

Also Published As

Publication number Publication date
NO932097D0 (en) 1993-06-09
KR940000108A (en) 1994-01-03
CN1037934C (en) 1998-04-08
CA2098410A1 (en) 1993-12-17
MX9303582A (en) 1994-04-29
EP0574822A1 (en) 1993-12-22
DE4219702A1 (en) 1993-12-23
NO932097L (en) 1993-12-17
AU656078B2 (en) 1995-01-19
IL105870A0 (en) 1993-10-20
JPH0665078A (en) 1994-03-08
IL105870A (en) 1996-12-05
FI932768A (en) 1993-12-17
FI932768A0 (en) 1993-06-16
IE930446A1 (en) 1993-12-29
AU4000993A (en) 1993-12-23
CN1083702A (en) 1994-03-16

Similar Documents

Publication Publication Date Title
ZA897437B (en) Pharmaceutical formulations
ZA895838B (en) Pharmaceutical compounds
ZA89260B (en) Pharmaceutical compounds
GB9201639D0 (en) Pharmaceutical formulations
ZA934222B (en) Pharmaceutical soft capsules containing lysine clonixinate
ZA885969B (en) Pharmaceutical preparations for external use
CZ87895A3 (en) Pharmaceutical preparation
GB9304549D0 (en) Apparatus for administration of drugs
PL298159A1 (en) Pharmaceutical preparation
GB9111587D0 (en) Drug capsule
IE871929L (en) Pharmaceutical preparations containing xylometazoline
GB8820343D0 (en) Pharmaceutical formulations
IE882439L (en) Pharmaceutical formulations
GB8828994D0 (en) Pharmaceutical formulations
GB8804790D0 (en) Pharmaceutical formulations
GB8813402D0 (en) Pharmaceutical formulations
GB8820272D0 (en) Pharmaceutical formulations
GB8810733D0 (en) Pharmaceutical formulations
GB8825297D0 (en) Pharmaceutical formulations
GB8820175D0 (en) Pharmaceutical formulations
GB8816609D0 (en) Pharmaceutical formulations
GB8820273D0 (en) Pharmaceutical formulations
GB8820271D0 (en) Pharmaceutical formulations
GB8826204D0 (en) Pharmaceutical compounds
GB8830078D0 (en) Pharmaceutical compounds